share_log

SELLAS Life Sciences Gr Analyst Ratings

Benzinga Analyst Ratings ·  Nov 15, 2022 21:36
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/15/2022 213.73% Alliance Global Partners $14 → $8 Maintains Buy
06/28/2022 135.29% Cantor Fitzgerald $10 → $6 Maintains Overweight
07/21/2021 605.88% Cantor Fitzgerald → $18 Initiates Coverage On → Overweight
11/15/2019 370.59% Maxim Group → $12 Upgrades Hold → Buy
04/08/2019 76.47% Alliance Global Partners → $4.5 Initiates Coverage On → Buy
11/01/2018 409.8% Oppenheimer → $13 Initiates Coverage On → Outperform
07/20/2018 96.08% Maxim Group $13 → $5 Maintains Buy
04/02/2018 331.37% HC Wainwright & Co. → $11 Initiates Coverage On → Buy
03/19/2018 Maxim Group Upgrades Hold → Buy

What is the target price for SELLAS Life Sciences Gr (SLS)?

The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Alliance Global Partners on November 15, 2022. The analyst firm set a price target for $8.00 expecting SLS to rise to within 12 months (a possible 213.73% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?

The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Alliance Global Partners, and SELLAS Life Sciences Gr maintained their buy rating.

When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.

Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?

While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a maintained with a price target of $14.00 to $8.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $2.55, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment